NEW YORK (GenomeWeb) – The National Institute of Mental Health plans to fund new research that will explore molecular and cellular alterations that are associated with complex brain disorders, and how they impact neuronal function.

NIMH said yesterday in a funding announcement it wants to spur more knowledge about how these alterations are involved in "some of the biggest challenges facing neuroscience" — disorders such as schizophrenia, depression, bipolar and anxiety disorders, and autism.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.